LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 11 of 497
Next
>>
>
251 to 275 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	PHA-665752	0.04	uM	LJP5	3	F18	72	hr	1657	5868	5505	1.0658	1.0942
BT-20	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1657	4591	5505	0.8339	0.7623
BT-20	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1657	6094	5505	1.1069	1.1529
BT-20	Mitoxantrone	0.12	uM	LJP5	1	C23	72	hr	1657	2154	5505	0.3912	0.1290
BT-20	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1657	5924	5505	1.0760	1.1087
BT-20	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	1657	5165	5505	0.9381	0.9115
BT-20	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1657	6352	5505	1.1537	1.2199
BT-20	PLX-4720	0.04	uM	LJP5	1	K06	72	hr	1657	5738	5505	1.0422	1.0604
BT-20	PLX-4720	0.04	uM	LJP5	2	K06	72	hr	1657	5796	5505	1.0527	1.0755
BT-20	PLX-4720	0.04	uM	LJP5	3	K06	72	hr	1657	5701	5505	1.0355	1.0508
BT-20	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1657	4512	5505	0.8195	0.7418
BT-20	Ruxolitinib	0.04	uM	LJP5	3	O18	72	hr	1657	5130	5505	0.9318	0.9024
BT-20	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1657	4978	5505	0.9042	0.8629
BT-20	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	1657	4934	5505	0.8962	0.8514
BT-20	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1657	5611	5505	1.0191	1.0274
BT-20	SU11274	0.04	uM	LJP5	2	J12	72	hr	1657	5838	5505	1.0604	1.0864
BT-20	Radicicol	0.04	uM	LJP5	1	K12	72	hr	1657	4853	5505	0.8815	0.8304
BT-20	Radicicol	0.04	uM	LJP5	2	K12	72	hr	1657	5305	5505	0.9636	0.9479
BT-20	Radicicol	0.04	uM	LJP5	3	K12	72	hr	1657	4989	5505	0.9062	0.8657
BT-20	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1657	5840	5505	1.0607	1.0869
BT-20	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	1657	5508	5505	1.0004	1.0006
BT-20	TGX221	0.04	uM	LJP5	3	H24	72	hr	1657	5322	5505	0.9666	0.9523
BT-20	Seliciclib	0.04	uM	LJP5	1	J06	72	hr	1657	5649	5505	1.0260	1.0372
BT-20	Nilotinib	0.12	uM	LJP5	2	N17	72	hr	1657	5368	5505	0.9750	0.9642
BT-20	Nilotinib	0.12	uM	LJP5	1	N17	72	hr	1657	5349	5505	0.9715	0.9593

|<
<<
Previous
Page 11 of 497
Next
>>
>
251 to 275 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)